Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | 1.32% | 697.33 | 2.6% | $644.85m | |
| MRNA | Moderna, Inc. | -0.55% | 123.64 | 0.0% | $634.51m | |
| AMGN | Amgen, Inc. | -0.34% | 226.97 | 1.4% | $624.69m | |
| GILD | Gilead Sciences, Inc. | -1.43% | 62.86 | 1.0% | $494.49m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.01% | 283.45 | 1.9% | $355.83m | |
| ILMN | Illumina, Inc. | -1.61% | 190.38 | 3.2% | $291.37m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -5.81% | 4.05 | 0.7% | $283.11m | |
| BIIB | Biogen, Inc. | -1.42% | 197.78 | 1.8% | $184.42m | |
| SAVA | Cassava Sciences, Inc. | -18.00% | 41.87 | 0.0% | $173.71m | |
| BNTX | BioNTech SE | -1.27% | 128.35 | 0.0% | $100.39m | |
| NRBO | NeuroBo Pharmaceuticals, Inc. | -6.44% | 15.54 | 0.0% | $89.03m | |
| NVAX | Novavax, Inc. | -6.42% | 21.00 | 75.6% | $85.66m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.09% | 84.84 | 4.2% | $76.07m | |
| EXAS | EXACT Sciences Corp. | -2.74% | 33.41 | 17.6% | $71.49m | |
| CRSP | CRISPR Therapeutics AG | -2.68% | 63.16 | 0.6% | $69.53m |
Company Profile
BiomX, Inc. operates as a clinical-stage microbiome company. It engages in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis, and colorectal cancer. The firm discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.